Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT02657382 Completed - Clinical trials for Coronary Artery Disease

Mental Stress Ischemia: Biofeedback Study

MIBS
Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the blood flow to the heart during stress and assess changes in blood flow after psychological treatment in participants with coronary artery disease. The aims of the study are to assess the effects of heart rate variability (HRV) biofeedback (versus usual care) on global and regional myocardial blood flow (MBF), peripheral vascular function, and autonomic changes during mental stress.

NCT ID: NCT02653326 Completed - Clinical trials for Cardiovascular Diseases

Technological Platforms and Telerehabilitation in Heart Surgery

Start date: January 2016
Phase: N/A
Study type: Interventional

In this randomised, double-blind, pilot study, the investigators aim to assess whether a telerehabilitation strategy could improve outcomes among patients with recent heart surgery. Included participants will receive a comprehensive rehabilitation programme comprised of physical therapy, nutritional counselling, psychological assistance in addition to standard medical care. After 12 sessions of physical therapy, patients will be randomised to receive telerehabilitation with a portable EKG device and a smartphone application or usual care. The primary endpoint for this study is the exercise capacity of included participants, which will be assessed using an ergospirometer at 4 and 8 weeks after randomisation.

NCT ID: NCT02652975 Completed - Metabolic Syndrome Clinical Trials

Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

ABCDE
Start date: September 2015
Phase: N/A
Study type: Interventional

Several cytotoxic regimens are related to endothelial cell damage and vascular toxicity. Endothelial dysfunction is implicated in the pathogenesis of all known cardiovascular diseases (CVD) and closely related to the metabolic syndrome. Both CVD and diabetes contributes importantly to total mortality and to breast cancer (BC) specific mortality. In the epidemiological part of the project, the investigators will determine the prevalence and incidence of cardiovascular and metabolic morbidity/mortality in early BC patients compared to the Danish background population. In the clinical part, the investigators will study the changes of endothelial function and metabolic parameters in BC patients receiving chemotherapy. With increasing number of BC survivors, long-term consequences of curative cancer treatment should be studied. The investigators hypothesize that cytotoxic therapy worsens metabolic parameters possibly through endothelial dysfunction. If this is true, the next step will be to evaluate how strict metabolic control will affect prognosis.

NCT ID: NCT02648464 Completed - Clinical trials for Cardiovascular Diseases

Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

OXI
Start date: February 1, 2016
Phase: Phase 4
Study type: Interventional

This safety pilot study evaluates the effect of hydroxychloroquine on preventing recurrent cardiovascular events among myocardial infarction patients. Half of the participants will receive hydroxychloroquine, whereas the other half will receive placebo during six months.

NCT ID: NCT02647333 Completed - Clinical trials for Cardiovascular Disease

Intervention With Omega Fatty Acids in High-risk Patients

Start date: March 2015
Phase: Phase 2
Study type: Interventional

In order to reduce cardiovascular risk, current European guidelines recommend a diet low on saturated fatty acid through replacement with polyunsaturated fatty acids (PUFA). Polyunsaturated fatty acids can be classified into omega-3 and omega-6. However the results from recent meta-analyses investigating coronary risk outcomes did not clearly support a low intake of saturated fatty acids and a high intake of omega-3 or omega-6. The aim of this study is to investigate the short term effects of a high intake of PUFAs on microvascular function, lipids, inflammation and other cardiovascular risk factors in inactive patients with increased waistline.

NCT ID: NCT02646488 Completed - Clinical trials for Cardiovascular Disease

Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease

Start date: August 2015
Phase: N/A
Study type: Interventional

The primary purpose of this study is to evaluate the effectiveness of practice facilitation as a quality improvement strategy for implementing the Million Hearts' ABCS treatment guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive care in primary care practices in New York City. The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). The long-term goal is to create a robust infrastructure to disseminate and implement evidence based practice guidelines (EBPG) findings in primary care practices and improve practices' capacity to receive and implement other EBPG findings in the future.

NCT ID: NCT02644239 Recruiting - Quality of Life Clinical Trials

Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy

Ketonutri
Start date: June 2012
Phase: N/A
Study type: Interventional

The ketogenic diet is a non-pharmacological treatment prescribed especially for children and indicated in most specialized centers for patients with refractory epilepsy. The composition of the ketogenic diet is based on high-fat, low-carbohydrate, moderate protein content, and the production of ketone bodies is the probable mechanism involved in the control of seizures. The relationship between the treatment of the ketogenic diet and changes in oxidative characteristics, physical and lipid are not well established. Some studies show a significant increase in total cholesterol and triglycerides in children being treated with ketogenic diet, but other studies have shown that changes in lipid profile in the long term do not appear to be significant, beyond the influence of these changes on coronary heart disease are unknown. The studies performed in the last two decades have shown that besides the changes in the lipid profile, oxidative modification of lipoproteins are essential for the initiation and progression of atherosclerosis and physical properties of lipoproteins also appear to be involved in this process, suggesting that the particle size of lipoproteins, through the analysis of subfractions can provide more details of the cardiovascular risk. Thus, this projetct aims to compare the effects of the classical ketogenic diet with the ketogenic diet modified with lower content of saturated fatty acids and a higher content of monounsaturated and polyunsaturated, the oxidative changes of LDL, lipidomic profile, the concentration of antioxidants in production inflammatory cytokines and the subfractions of LDL and HDL in children and adolescents with refractory epilepsy, the clinical effect on controlling epilepsy.

NCT ID: NCT02641834 Completed - Clinical trials for Cardiovascular Disease

Prevention of Cardiovascular Disease With Med or Veg Diets

CARDIVEG
Start date: January 2016
Phase: N/A
Study type: Interventional

The study is a randomized, open, cross-over trial designed to test whether a vegetarian diet would benefit the cardiovascular risk profile of the participants, compared with a Mediterranean diet.

NCT ID: NCT02641197 Completed - Clinical trials for Cardiovascular Diseases

Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study

Start date: April 6, 2016
Phase: N/A
Study type: Interventional

The objective of this study is to define the repeatability and reproducibility of quantifying flow-mediated dilation (FMD) of the brachial artery (BA) using the AngioDefender (AD) methodology. Repeatability will be assessed by repeat AD testing of the same subject 1 hour apart, using the same AD device and operator. Reproducibility will be assessed by comparing FMD scores obtained for the same subject, but using different AD devices and operators.

NCT ID: NCT02640859 Completed - Clinical trials for Cardiovascular Disease

Investigation of Metabolic Risk in Korean Adults

Start date: September 2015
Phase:
Study type: Observational [Patient Registry]

A cohort study with Korean adults to investigate biomarkers in prediction of cardiometabolic and other diseases